Anti-chemotactic activities of peptide-T: A possible mechanism of actions for its therapeutic effects on psoriasis

International Journal of Immunopharmacology

Volumn 20, Issue 11, 1998, Pages 661-667

  Raychaudhuri, Smriti K ^a   Raychaudhuri, Siba P ^a   Farber, Eugene M ^a  

^a Psoriasis Research Institute   (United States)

Author keywords

Anti inflammatory actions; Peptide T; Psoriasis

Indexed keywords

PEPTIDE T; RANTES;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; MALE; MONOCYTE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PSORIASIS;

ADULT; CHEMOTAXIS, LEUKOCYTE; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; PEPTIDE T; PSORIASIS; RANTES; T-LYMPHOCYTES;

EID: 0032477295     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(98)00020-4     Document Type: Article

References (27)

1. Burdette S., Schwartz R. T. N. Engl. J. Med. 17:1987;219-223.
2. Christophers E., Parzefall R., Braun-Falco O. Br. J. Dermatol. 89:1973;327-334.
3. Christophers, E., Sterry, W. (1993). Psoriasis. In Fitzpatrick, T. B., Eisen, A. Z., Wolff, K., et al., (Eds.), Dermatology in general medicine. New York: McGraw-Hill, 489-514.
4. Cocchi F., DeVico A. L., Garzino-Demo A., Cara A., Gallo R. C., Lusso P. Nature. Med. 2:1996;1244-1247.
5. Cocchi F., Devico A. L., Garzino-Demo A., Arya S. K., Gallo R. C., Lusso P. Science. 270:1995;1811-1815.
6. Farber E. M., Cohen E. N., Trozak D., Wilkinson D. I. J. Amer. Acad. Dermatol. 25:1991;658-664.
7. Farber, E. M., Raychaudhuri, S. P., Jiang, W.-Y., Schall, T. J., Ruff, M. R., and Pert, C. B. (1998). Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis. Acta. Derm. Venereol. in press.
8. Geissler K., Tricot G., Leemhuis T., Walker E., Broxmeyer H. E. Cancer Res. 49:1989;3057-3062.
9. Gillitzer R., Wolff K., Tong D. J. Invest. Dermatol. 101:1993;27-31.
10. Iversen O. J., Dalen A. B. Arch. Virol. 85:1985;197-207.
11. Johansson O., Hilliges M., Talme T., Marcusson J. A., Wetterberg L. Acta. Derm. Venereol. 74:1994;106-109.
12. Kelvin D., Michiel D. F., Johnston J. A. J. Leukoc. Biol. 177:1993;1421-1427.
13. Kulke R., Todt-Pingel I., Rdemacher D., Rowert J., Schroder J., Christophers E. J. Invest. Dermatol. 106:1996;526-530.
14. Marcusson J. A., Wetterberg L. Acta. Derm. Venerol. 69:1989;86-88.
15. Marcusson J. A, Lazega D., Pert C.B. Acta. Derm. Venerol. 146:1989;117-121.
16. Murphy P. M. Annu. Rev. Immunol. 12:1994;593-633.
17. Pert C. B., Hill J. M., Ruff M. R. Proc. Natl. Acad. Sci. U.S.A. 83:1986;9254-9258.
18. Ramirez-Bosca M., Martinez-Ojeda L., Valcuende-Cavero F., Castells-Rodellas A. Br. J. Dermatol. 119:1989;587-595.
19. Ruff M. R., Martin B. M., Ginns E. I., Farrar W. L., Pert C. B. FEBS letters. 211:1987;17-22.
20. Ruff M. R., Halberg P. L., Hill J. M. Lancet. 2:1987;751.
21. Schall T. J., Bacon K., Toy K. J., Goeddel D. V. Nature. 347:1990;669-671.
22. Tagami H., Iwatsuki K., Takematsu H. J. Invest. Dermatol. 88:1987;18-23.
23. Ternowitz T. J. Am. Acad. Dermatol. 15:1986;1191-1199.
24. Van den Oord J. J., de Wolf-Peeters C. Br. J. Dermatol. 130:1994;589-594.
25. Wetterberg L., Alexius B., Saaf J. Lancet. 1:1987;159.
26. Wortmann S., Boehncke W-H., Mielke V. Arch. Dermatol. 285:1993;85.
27. Yoshimura T., Matsushima K., Tanaka S. Proc. Natl. Acad. Sci. USA. 84:1987;9233-9237.